GESTIÓN EN SALUD PÚBLICA: Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling - 01/26/2021 - 01/26/2021 | FDA

miércoles, 18 de noviembre de 2020

Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling - 01/26/2021 - 01/26/2021 | FDA

Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling - 01/26/2021 - 01/26/2021 | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)